Applied Therapeutics files Form 12b-25 with SEC

Applied Therapeutics (APLT) has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission related to the Company’s Annual Report on Form 10-K for the fiscal year 2024. Form 12b-25 will allow the Company an automatic extension of 15 additional calendar days to file the Form 10-K for the fiscal year 2024, which is due on March 31, 2025. The Company is working diligently to finalize its financial statements and currently expects to file its Annual Report on Form 10-K as soon as practicable by April 15, 2025, the end of the 15-day extension period, in accordance with Rule 12b-25.